HaGiMo's Adverse Event
Monitoring ('AEM') system constantly scans trillions of updated data points, searching for variances in incidence rates and co-morbidities in groups of patients that share a similar procedure or prescription history. Made possible by the depth of the longitudinal database and the AI-driven low-level parse and scan engines, the monitoring daemon can check thousands of compounds and devices across hundreds of millions of patient histories monthly, and generate flags and alerts when statistically significant variations from normal values are detected. This intelligence can have a profound effect on several verticals:
AEM business intelligence is based on Isometry Analytics
and 'simple congruence mapping', where the medical histories of a group of individuals that share a common prescription or procedure are compared with the general population of more than 120M health histories. Trillions of data points and trillions more potential combinations, all parsed and compared on a supercomputing platform (parallel processing, thousands of processors) purpose-built to perform just one function: find the problems with these compounds and devices, and find them long before anyone else.
1. For reports over longer periods of time, please contact HaGiMo for more information.
The Adverse Event Monitoring service and associated analytics packages can make the difference between a minor PR gaffe and a multi-million dollar mistake - one that could have been avoided. A complete AEM / isometry analysis, whether applied to a single device from a small biomed or across the entire portfolio of a top 10 pharma represents a data-driven early warning system that identifies unforeseen issues associated with a specific product line, often years before anyone is even talking about it. This affords payers an opportunity to save millions of dollars in claims paid out based on defective products. The service and savings can drive more competitive rates to clients, offer a clear advantage over your competitors in the local, regional, and national marketplace, and have a direct, real impact on your ROI. Exclusive licensing is also available, based on specific vendors, devices, compounds, or families of devices and compounds, or across specific geographic regions, etc.
For more information, please contact HaGiMo, LLC.